Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pain, Intractable: later-stage trial registry
1 of 4 indexed Pain, Intractable trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 1 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Pain, Intractable: 4 US clinical trials tracked, 1 recruiting.
Pain, Intractable is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Evolve Restorative Center, running 1 of these trials.
Enrollment posture brief
Registry condition pain-intractable
OPEN 1 | RECR 25% | LATE 1 | EARLY 0 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Cancer (25% recruiting · 8 trials)
Pain, Intractable lists 1 open slots (25% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pain, Intractable on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pain, Intractable is recruiting below its size-band peers.
1 of 4 indexed trials (25%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Sensory Spinal Cord Stimulation
University of North Carolina, Chapel Hill
NCT07095036
Intermittent vs. Continuous Dorsal Root Ganglion Stimulation
Spine and Pain Institute of New York
NCT04727216
Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population
Evolve Restorative Center
NCT04096391
An Implantable Spinal Cord Stimulation Pain Management System
Boston Scientific Corporation
NCT00205855
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 3 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pain, Intractable records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pain, Intractable trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pain, Intractable page
4 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Pain, Intractable trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Evolve Restorative Center sponsors the most Pain, Intractable trials on record, review their full trial history before evaluating a specific study. See Evolve Restorative Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pain, Intractable condition card totals 4 registered trials; most-linked intervention Precision SCS; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.